J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text HTML] [Full Text PDF] （in Japanese / 1901KB） [Members Only]

J.Jpn. Surg. Soc.. 125(4): 303-309, 2024

Feature topic

PROGRESS AND FUTURE PROSPECTS OF ROBOT-ASSISTED THORACOSCOPIC SURGERY FOR LUNG CANCER

1) Division of General Thoracic Surgery, Department of General Thoracic Surgery, Matsue Red Cross Hospital, Matsue, Japan
2) Department of Surgery, Faculty of Medicine, Tottori University, Yonago, Japan

Hiroshige Nakamura1), Tomohiro Haruki2), Yasuaki Kubouchi2), Shinji Matsui2), Takashi Ohno1)

Recently, robot-assisted thoracoscopic surgery for lung cancer has been spreading rapidly in Japan. This is largely due to national insurance coverage for lobectomy starting in 2018 and segmentectomy in 2020, respectively. The results of many systematic reviews, meta-analyses, and prospective randomized controlled trials were reported from overseas, and robotic surgery was shown to have the same or better results than thoracotomy and thoracoscopic surgery. As a result, in the Lung Cancer Clinical Practice Guidelines in 2022 and 2023, robotic surgery is recommended as Grade 2B and established as minimally invasive surgery for lung cancer. Robotic surgery has good maneuverability and can facilitate meticulous operations for blood vessels and bronchi and lymph node dissection of the hilum and mediastinum with high accuracy. Consequently, the more difficult surgery, such as in cases of advanced cancer, surgery after preoperative therapy, and segmentectomy, the more useful this approach is. Although there is no clear evidence supporting the advantages of robotic surgery for lung cancer in Japan, the advent of new surgical robots has led to the next stage. There are several expectations for robotic surgical evolution such as the use of digital data and the development of surgical support functions using AI.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.